I-MAB ( $IMAB )
Recent earnings result
Events & PresentationsI Mab's IMAB CEO Joan Huaqiong Shen on Q2 2020 Results
Events & Annual meetings
|I Mab's IMAB CEO Joan Huaqiong Shen on Q2 2020 Results||9/1/2020||webcast|
We are a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. Our mission is to bring transformational medicines to patients through innovation.
Videos about I-MAB
For list of IMAB events, you may visit their Investor Relations website.
$HRB - H&R Block, Inc.
H&R Block EPS beats by $0.21, misses on revenue
$SCVL - Shoe Carnival, Inc.
Shoe Carnival EPS beats by $0.13, misses on revenue
$CAL - Caleres, Inc.
Caleres EPS beats by $0.45, beats on revenue
$HOME - At Home Group
At Home Group EPS beats by $0.10, revenue in-line
$JAMF - Jamf Holding Corp
Jamf EPS misses by $0.02, beats on revenue
$CDMO - Avid Bioservices, Inc.
Avid Bioservices EPS beats by $0.13, beats on revenue
$BBW - Build-A-Bear Workshop, Inc.
Build-A-Bear Workshop EPS beats by $0.19, beats on revenue
$WSG - Wanda Sports Group
Wanda Sports EPS beats by $0.36, beats on revenue
$SCSC - ScanSource, Inc.
ScanSource EPS misses by $0.02, beats on revenue
$ZM - Zoom Video Communications
Zoom Video Communications EPS beats by $0.47, beats on revenue